Suppr超能文献

中国河北省男男性行为初治人群中HIV-1的流行趋势、基因特征及传播网络

Epidemic trend, genetic characteristics, and transmission networks of HIV-1 among treatment-naive men who have sex with men in Hebei province, China.

作者信息

Lu Xinli, Wang Yingying, Ma Lin, Liu Meng, Li Yan, An Ning, Zhang Xinyu, Tang Xiangyun, Li Qi

机构信息

Department of AIDS Research, Hebei Key Laboratory of Pathogen and Epidemiology of Infectious Disease, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.

出版信息

Front Microbiol. 2024 Aug 8;15:1405565. doi: 10.3389/fmicb.2024.1405565. eCollection 2024.

Abstract

INTRODUCTION

Homosexual transmission has contributed greatly to the current HIV-1 epidemic in Hebei province, China. Dolutegravir (DTG) will be conditionally used as a component of free antiretroviral therapy (ART) according to manual for national free anti-AIDS treatment drugs (2023 edition) issued by China in June 2023. However, current genetic characteristics and pretreatment drug resistance (PDR) to proteinase inhibitors (PIs), reverse transcriptase inhibitors (RTs) and integrase strand transfer inhibitors (INSTIs) of HIV-1 in this population have remained unclear.

METHODS

Serial consecutive cross-sectional analyses for HIV- 1 infection trend, genetic characteristics, PDR and molecular transmission networks were conducted from 2018 to 2022. All of participants were HIV-1- infected MSM newly diagnosed at the HIV surveillance points (HSPs) in Hebei, China. Evidence of PDR was confirmed using the world health organization (WHO) list for surveillance of drug resistance mutations.

RESULTS

In this study, a total of 14 HIV-1 subtypes were circulating in the HSPs of Hebei province, China. CRF01_ AE (51.9%, 350/675), CRF07_BC (30.4%, 205/675), B (6.2%, 42/675) and URFs (5.8%, 39/675) were the four most predominant subtypes among MSM. And, CRF07_BC ( > 0) and URFs ( > 0) indicated an increasing trend, respectively; however, CRF01_AE ( < 0) showed a decline trend. The overall prevalence of HIV-1 PDR showed a substantial increase from 6.3% in 2018 to 7.9% in 2022. The prevalence of NNRTI-PDR was the highest (5.8%, 39/675), followed by INSTIs (2.4%, 16/675), NRTIs (0.6%, 4/675) and PIs (0.3%, 2/675). Furthermore, extensive HIV-1 strains bearing PDR were circulating in the MSM population via molecular transmission networks for major HIV-1 subtypes, especially CRF01_AE and CRF07_BC.

DISCUSSION

Our findings reflect that HIV-1 epidemic in the MSM population is complex and severe in Hebei, China. Therefore, it is urgent for us to implement more effective intervention measures to limit the further dissemination of HIV-1, especially the spread of HIV-1 INSTI-PDR strains.

摘要

引言

在中国河北省,同性传播在当前HIV-1流行中起到了很大作用。根据中国于2023年6月发布的《国家免费艾滋病抗病毒治疗药品手册(2023年版)》,多替拉韦(DTG)将被有条件地用作免费抗逆转录病毒疗法(ART)的一个组成部分。然而,该人群中HIV-1目前的基因特征以及对蛋白酶抑制剂(PIs)、逆转录酶抑制剂(RTs)和整合酶链转移抑制剂(INSTIs)的治疗前耐药性(PDR)仍不清楚。

方法

对2018年至2022年期间HIV-1感染趋势、基因特征、PDR和分子传播网络进行了系列连续横断面分析。所有参与者均为在中国河北省HIV监测点(HSPs)新诊断的HIV-1感染男男性行为者(MSM)。使用世界卫生组织(WHO)耐药突变监测清单确认PDR证据。

结果

在本研究中,中国河北省的HSPs中共流行14种HIV-1亚型。CRF01_AE(51.9%,350/675)、CRF07_BC(30.4%,205/675)、B(6.2%,42/675)和未定型重组形式(URFs,5.8%,39/675)是MSM中四种最主要的亚型。并且,CRF07_BC(>0)和URFs(>0)分别呈上升趋势;然而,CRF01_AE(<0)呈下降趋势。HIV-1 PDR的总体患病率从2018年的6.3%大幅上升至2022年的7.9%。非核苷类逆转录酶抑制剂(NNRTI)-PDR的患病率最高(5.8%,39/675),其次是整合酶链转移抑制剂(INSTIs,2.4%,16/675)、核苷类逆转录酶抑制剂(NRTIs,0.6%,4/675)和蛋白酶抑制剂(PIs,0.3%,2/675)。此外,携带PDR的广泛HIV-1毒株通过主要HIV-1亚型的分子传播网络在MSM人群中传播,尤其是CRF01_AE和CRF07_BC。

讨论

我们的研究结果反映出中国河北省MSM人群中的HIV-1流行情况复杂且严峻。因此,我们迫切需要实施更有效的干预措施,以限制HIV-1的进一步传播,尤其是HIV-1整合酶链转移抑制剂耐药毒株的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e9/11339959/5bbe73e3e650/fmicb-15-1405565-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验